What to Expect in Medical Detox

On arrival at Scottsdale Detox, you are seen immediately by the medical team. The admissions assessment covers your substance use history, current medications, any co-occurring medical or psychiatric conditions, and vital signs.

Based on this assessment, your care plan is designed before any withdrawal symptoms escalate. Clinical staff establish your baseline and begin any indicated medications. You are shown to a private room with an en-suite bathroom. Cell phone and laptop access are available throughout your stay.

The facility also has a 24/7 café and DIRECTV access. The environment is not what many people expect.

For alcohol withdrawal, the first symptoms typically appear six to 12 hours after the last drink. Early symptoms include anxiety, restlessness, mild tremors, elevated heart rate, and sweating.

Clinical staff use the Clinical Institute Withdrawal Assessment for Alcohol, known as the CIWA protocol, to score withdrawal severity at regular intervals. The CIWA score guides medication decisions throughout withdrawal. If your score indicates significant risk, benzodiazepines are typically initiated at this stage to prevent escalation.

Heart rate and blood pressure may continue to increase during this window. Tremors may become more pronounced. Nausea, vomiting, and insomnia are common.

Nursing staff assesses you regularly during this period. Medications are adjusted based on your CIWA score and clinical presentation. The goal is to keep symptoms at a manageable level while preventing progression to more serious complications.

You are not alone during this stage. Nursing staff check in frequently.

The 24- to 72-hour window carries the highest risk of serious alcohol withdrawal complications, including hallucinations and, in severe cases, seizures. Most patients do not experience these complications when detox is medically managed from the start.

For patients with a history of severe alcohol withdrawal, more aggressive preventive treatment may be initiated earlier. Clinical monitoring during this period is intensive.

For most patients, symptoms begin to decrease significantly after day three. Benzodiazepine dosing is gradually tapered as your CIWA scores improve. Appetite typically returns. Sleep, while often disrupted, begins to stabilize.

By the end of the acute detox period, most patients are physically stable and ready to discuss next steps in treatment.

Some patients experience post-acute withdrawal syndrome, known as PAWS, in the weeks following acute detox. PAWS symptoms include mood disturbances, sleep disruption, reduced concentration, and persistent cravings.

These symptoms are less acute than the initial withdrawal period but require clinical attention. They are typically managed through ongoing therapy and, where appropriate, medication-assisted treatment.

Benzodiazepines are the primary evidence-based treatment for alcohol withdrawal. They reduce the central nervous system excitability that drives withdrawal symptoms and seizure risk. Specific medications may include diazepam, lorazepam, or chlordiazepoxide, chosen based on your clinical presentation and history.

Buprenorphine, commonly known as Suboxone, is typically the first-line medication for opioid detox. It reduces withdrawal symptoms and cravings without significant euphoria. Clonidine may be used as an adjunct to manage autonomic symptoms, including sweating, elevated heart rate, and anxiety. Methadone is an alternative for opioid detox and is also used as a long-term maintenance option. Naltrexone is an opioid blocker used after acute detox is complete to help prevent relapse.

Benzodiazepine withdrawal can be life-threatening and must always be medically managed. A gradual taper using a longer-acting benzodiazepine is the standard approach. Abrupt cessation of benzodiazepines carries a serious risk, including seizures, and should never be attempted without clinical supervision.